Researcher profile

Raul Isea

Raul Isea contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
9works
0followers
8topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

9 published item(s)

preprint2013arXiv

Application of CellDesigner to the Selection of Anticancer Drug Targets: Test Case using P53

Cancer is a disease involving many genes, consequently it has been difficult to design anticancer drugs that are efficacious over a broad range of cancers. The robustness of cellular responses to gene knockout and the need to reduce undesirable side effects also contribute to the problem of effective anti-cancer drug design. To promote the successful selection of drug targets, each potential target should be subjected to a systems biology scrutiny to locate effective and specific targets while minimizing undesirable side effects. The gene p53 is considered a good candidate for such a target because it has been implicated in 50% of all cancers and is considered to encode a hub protein that is highly connected to other proteins. Using P53 as a test case, this paper explores the capacity of the systems biology tool, CellDesigner, to aid in the selection of anticancer drug targets and to serve as a teaching resource for human resource development.

preprint2010arXiv

Advances in the Biomedical Applications of the EELA Project

In the last years an increasing demand for Grid Infrastructures has resulted in several international collaborations. This is the case of the EELA Project, which has brought together collaborating groups of Latin America and Europe. One year ago we presented this e-infrastructure used, among others, by the Biomedical groups for the studies of oncological analysis, neglected diseases, sequence alignments and computation phylogenetics. After this period, the achieved advances are summarised in this paper.

preprint2010arXiv

Identificación de nuevos medicamentos a través de métodos computacionales

Resumen: El desarrollo de nuevos medicamentos es un problema complejo que carece de una solución única y automática desde un punto de vista computacional, debido a la carencia de programas que permitan manejar grandes volúmenes de información que están distribuidos a lo largo de todo el mundo entre múltiples bases de datos. Por ello se describe una metodología que permita realizar experimentos in silico para la identificación actual de nuevos medicamentos. Abstract: The development of new drugs is a problem that nowadays has no solution in terms of computational power due to the lack of software for handling the big volume of available information; besides, these data are stored in multiple formats and are distributed all around the world. To resolve that, a development of an in silico drug design methodology.

preprint2010arXiv

Identification of 11 potential malaria vaccine candidates using Bioinformatics

In this paper, we suggested eleven protein targets to be used as possible vaccines against Plasmodium falciparum causative agent of almost two to three million deaths per year. A comprehensive analysis of protein target have been selected from the small experimental fragment of antigen in the P. falciparum genome, all of them common to the four stages of the parasite life cycle (i.e., sporozoites, merozoites, trophozoites and gametocytes). The potential vaccine candidates should be analyzed in silico technique using various bioinformatics tools. Finally, the possible protein target according to PlasmoDB gene ID are PFC0975c, PFE0660c, PF08_0071, PF10_0084, PFI0180w, MAL13P1.56, PF14_0192, PF13_0141, PF14_0425, PF13_0322, y PF14_0598.

preprint2010arXiv

Phylogenetic tree calculations using the Grid with DAG job

The goal of the work is to implement molecular phylogenetic calculations using the Grid paradigm by means of the MrBayes software using Directed Acyclic Graphs (DAG) jobs. In this method, a set of jobs depends on the input or the output of other jobs. Once the runs have been successfully done, all the results can be collected by a specific Perl script inside the defined DAG job. For testing this methodology, we calculate the evolution of papillomavirus with 121 sequences.

preprint2010arXiv

PhyloGrid: a development for a workflow in Phylogeny

In this work we present the development of a workflow based on Taverna which is going to be implemented for calculations in Phylogeny by means of the MrBayes tool. It has a friendly interface developed with the Gridsphere framework. The user is able to define the parameters for doing the Bayesian calculation, determine the model of evolution, check the accuracy of the results in the intermediate stages as well as do a multiple alignment of the sequences previously to the final result. To do this, no knowledge from his/her side about the computational procedure is required.

preprint2010arXiv

The Virtual Institute for Integrative Biology (VIIB)

The Virtual Institute for Integrative Biology (VIIB) is a Latin American initiative for achieving global collaborative e-Science in the areas of bioinformatics, genome biology, systems biology, metagenomics, medical applications and nanobiotechnolgy. The scientific agenda of VIIB includes: construction of databases for comparative genomics, the AlterORF database for alternate open reading frames discovery in genomes, bioinformatics services and protein simulations for biotechnological and medical applications. Human resource development has been promoted through co-sponsored students and shared teaching and seminars via video conferencing. E-Science challenges include: interoperability and connectivity concerns, high performance computing limitations, and the development of customized computational frameworks and flexible workflows to efficiently exploit shared resources without causing impediments to the user. Outreach programs include training workshops and classes for high school teachers and students and the new Adopt-a-Gene initiative. The VIIB has proved an effective way for small teams to transcend the critical mass problem, to overcome geographic limitations, to harness the power of large scale, collaborative science and improve the visibility of Latin American science It may provide a useful paradigm for developing further e-Science initiatives in Latin America and other emerging regions.